5 June 2024 in Clinical Chemistry and Laboratory Medicine (CCLM)
Background: The EFLM Task and Finish Group Urinalysis has updated the ECLM European Urinalysis Guidelines (2000) on urinalysis and urine bacterial culture, to improve accuracy of these examinations in European clinical laboratories, and to support diagnostic industry to develop new technologies. Recommendations: Graded recommendations were built in the following areas: Medical needs and test requisition: Strategies of urine testing are described to patients with complicated or uncomplicated urinary tract infection (UTI), and high or low-risk to kidney disease. Specimen collection: Patient preparation, and urine collection are supported with two quality indicators: contamination rate (cultures), and density of urine (chemistry, particles). Chemistry: Measurements of both urine albumin and α1-microglobulin are recommended for sensitive detection of kidney disease in high-risk patients. Performance specifications are given for urine protein measurements and quality control of multiproperty strip tests. Particles: Procedures for microscopy are reviewed for diagnostic urine particles, including urine bacteria. Technologies in automated particle counting and visual microscopy are updated with advice how to verify new instruments with the reference microscopy. Bacteriology: Chromogenic agar is recommended as primary medium in urine cultures. Limits of significant growth are reviewed, with an optimised workflow for routine specimens, using leukocyturia to reduce less important antimicrobial susceptibility testing. Automation in bacteriology is encouraged to shorten turn-around times. Matrix assisted laser desorption ionization time-of-flight mass spectrometry is applicable for rapid identification of uropathogens. Aerococcus urinae, A. sanguinicola and Actinotignum schaalii are taken into the list of uropathogens. A reference examination procedure was developed for urine bacterial cultures.
26 December 2024 in Virulence
Specific determinants associated with Uropathogenic Escherichia coli (UPEC) causing recurrent cystitis are still poorly characterized. Using strains from a previous clinical study (Vitale study, clinicaltrials.gov, identifier NCT02292160) the aims of this study were (i) to describe genomic and phenotypic traits associated with recurrence using a large collection of recurrent and paired sporadic UPEC isolates and (ii) to explore within-host genomic adaptation associated with recurrence using series of 2 to 5 sequential UPEC isolates. Whole genome comparative analyses between 24 recurrent cystitis isolates (RCIs) and 24 phylogenetically paired sporadic cystitis isolates (SCIs) suggested a lower prevalence of putative mobile genetic elements (MGE) in RCIs, such as plasmids and prophages. The intra-patient evolution of the 24 RCI series over time was characterized by SNP occurrence in genes involved in metabolism or membrane transport and by plasmid loss in 5 out of the 24 RCI series. Genomic evolution occurred early in the course of recurrence, suggesting rapid adaptation to strong selection pressure in the urinary tract. However, RCIs did not exhibit specific virulence factor determinants and could not be distinguished from SCIs by their fitness, biofilm formation, or ability to invade HTB-9 bladder epithelial cells. Taken together, these results suggest a rapid but not convergent adaptation of RCIs that involves both strain- and host-specific characteristics.
1 May 2026 in The French Journal of Urology
24 June 2026 in Microbiology Spectrum
Despite its dominance as a commensal, Staphylococcus lugdunensis (SLU) is a particularly virulent coagulase-negative Staphylococcus that is predominantly associated with community-acquired soft-tissue and skin infections. The aim of our study was to identify genotypic and phenotypic traits associated with the clinical presentations of SLU-associated infections, such as prosthetic joint infections, infective endocarditis (IE), and skin and soft tissue infections. Between January 2001 and December 2016, 73 pathogenic (including 18 strains responsible for IE) and 3 nonpathogenic SLU strains were retrospectively collected from nine French hospitals. All the strains belonged to six clonal complexes (CC1 to CC6) and 12 sequence types (STs). Interestingly, the capacity of the IE-associated strains to bind the von Willebrand factor was greater than that of the other strains, regardless of the CC. Biofilm formation was significantly increased for the most common CCs involved in infections (CC1, CC2, and CC3) and for IE-associated strains. The ability of SLU to inhibit other pathogens varied depending on the CCs caused by specific mutations within the lug operon that resulted in truncated protein expression. Genetic variants from genome virulence genes such as agrC and atIL also vary according to STs. The Galleria mellonella infection model revealed that CC4 was more virulent than the other CCs. On the basis of a large sequenced collection of SLU strains, we found that important phenotypic variation occurred among clinical strains and seemed to be related to some type of infection. IMPORTANCE: Staphylococcus lugdunensis is a coagulase-negative Staphylococcus recognized for its virulence in human clinical infections. However, few studies have focused on investigating the phenotypic and genotypic aspects, as well as the population characteristics, of clinical strains involved in severe invasive infections such as endocarditis or skin and soft tissue infections, or of strains associated with so-called cutaneous carriage. Here, we compared different virulence gene variants in terms of populational aspects and also highlighted important phenotypic trait changes according to the clinical presentation and site of isolation of the strains.